Valuation : Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.32B 3.87B 493M 426M 401M 365M 683M 46.61B 688M 4.75B 1.84B 23.83B 1.85B 1.81B 78.28B P/E 2026 *
7.29x
P/E 2027 * 6.47x
Enterprise Value 3.32B 3.87B 493M 426M 401M 365M 683M 46.61B 688M 4.75B 1.84B 23.83B 1.85B 1.81B 78.28B EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.44x
Free-Float
45.7%
Yield 2026 *
6.18%
Yield 2027 * 6.95%
08-28 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-28 Tong Ren Tang Technologies Co. Ltd. Enters New E-Commerce Service Cooperation Framework Agreement with Beijing Tong Ren Tang Shuzi Technology Co., Ltd CI
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-27 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
1 day-1.47%
1 week-5.18%
Current month+2.20%
1 month-14.20%
3 months-14.69%
6 months-31.05%
Current year-31.52%
1 week 2.96
Extreme 2.955
3.3
1 month 2.96
Extreme 2.955
3.57
Current year 2.96
Extreme 2.955
4.56
1 year 2.96
Extreme 2.955
5.02
3 years 2.96
Extreme 2.955
7.03
5 years 2.96
Extreme 2.955
9.28
10 years 2.96
Extreme 2.955
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 43 28/11/2025
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%-5.18%-37.99%-51.99% 501M
-0.16%+1.20%-14.66%-7.26% 13.45B
-0.71%-1.69%-33.92%-56.88% 4.9B
-0.36%-3.01%-8.51%-5.52% 4.52B
-1.81%-2.11%-5.86%-31.64% 3.99B
-0.72%-0.61%-21.46%+1.39% 3.57B
-2.27%+0.32%-2.80%-4.50% 3.51B
-0.88%-0.81%-11.39%+4.57% 3.28B
-1.46%-3.14%-25.48%-14.97% 2.36B
-1.08%+0.15%-27.68%-16.31% 1.72B
Average -1.09%-1.97%-18.97%-18.31% 4.18B
Weighted average by Cap. -0.81%-1.11%-16.16%-14.66%

Financials

2026 *2027 *
Net sales 6.98B 8.15B 1.04B 896M 844M 769M 1.44B 98.14B 1.45B 10B 3.88B 50.18B 3.9B 3.82B 165B 7.56B 8.83B 1.13B 971M 915M 833M 1.56B 106B 1.57B 10.83B 4.2B 54.35B 4.23B 4.13B 179B
Net income 454M 530M 67.63M 58.34M 54.96M 50.08M 93.6M 6.39B 94.3M 651M 253M 3.27B 254M 248M 10.73B 514M 599M 76.41M 65.92M 62.09M 56.58M 106M 7.22B 107M 735M 285M 3.69B 287M 281M 12.12B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
02/09/26 HK$3.020 -1.47% 961,000
01/09/26 HK$3.065 +3.72% 3,501,000
31/08/26 HK$2.955 -10.18% 18,889,925
28/08/26 HK$3.290 +2.33% 542,146
27/08/26 HK$3.215 -1.68% 830,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.589CNY
Average target price
4.601CNY
Spread / Average Target
+77.72%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock